Optometrist · Winston Salem, NC
NPI
1477589042
Since 2006
Specialty
Optometrist
Code 152W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
1340 Creekshire Way Ste 100
Winston Salem, NC, 27103
Phone (336) 768-3240
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
2,377 services
Medicare patients, 2024
622
Average age 76
Drug cost, 2024
$1.0M
6,445 prescriptions
Company payments, 2025
$253
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melissa A Barbor was code 99214 (office e&m - established), 792 times for 501 patients. In total Melissa A Barbor billed 2,377 services in 22 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 792 | 501 | $78.14 | $62K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 364 | 240 | $11.88 | $4,323 |
| 83861 Clinical Chemistry | Office | 350 | 125 | $21.91 | $7,669 |
| 92083 Vision, Hearing, and Speech Services | Office | 214 | 196 | $41.37 | $8,852 |
| 92133 Computerized Ophthalmic Imaging | Office | 209 | 206 | $22.06 | $4,611 |
| 83516 Immunoassay | Office | 132 | 56 | $11.30 | $1,492 |
| 99204 Office E&M - New | Office | 96 | 96 | $102.58 | $9,847 |
| 99213 Office E&M - Established | Office | 69 | 59 | $61.20 | $4,223 |
| 92285 Standard X-ray | Office | 39 | 39 | $16.81 | $655 |
| 92134 Computerized Ophthalmic Imaging | Office | 25 | 24 | $28.51 | $713 |
| 67820 Eye | Office | 23 | 19 | $13.03 | $300 |
| 99211 Office E&M - Established | Office | 11 | 11 | $17.19 | $189 |
By year: 2022 $85K for 1,580 services; 2023 $116K for 2,166 services; 2024 $110K for 2,377 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 350 | 125 | $21.91 | $7,669 |
| 83516 Immunoassay | 132 | 56 | $11.30 | $1,492 |
Medicare prescription drug claims, 2024
In 2024, the drug Melissa A Barbor prescribed most often to Medicare patients was Latanoprost, with 1,579 prescriptions and refills. In total Melissa A Barbor wrote 6,445 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,579 | 3,476 | 440 | $21K |
| Brimonidine Tartrate Generic | 843 | 1,675 | 238 | $14K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 830 | 1,970 | 260 | $12K |
| Dorzolamide Hcl Generic | 433 | 923 | 116 | $9,121 |
| Restasis Cyclosporine | 392 | 515 | 141 | $312K |
| Timolol Maleate Generic | 284 | 664 | 86 | $5,132 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 205 | 353 | 55 | $128K |
| Lumigan Bimatoprost | 182 | 335 | 45 | $91K |
| Rhopressa Netarsudil Mesylate | 177 | 286 | 52 | $81K |
| Prednisolone Acetate Generic | 146 | 198 | 94 | $5,241 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 121 | 132 | 94 | $1,582 |
| Miebo Perfluorohexyloctane/Pf | 104 | 152 | 27 | $92K |
| Erythromycin Erythromycin Base | 100 | 102 | 42 | $1,030 |
| Xiidra Lifitegrast | 97 | 107 | 38 | $74K |
| Doxycycline Monohydrate Generic | 92 | 114 | 41 | $1,812 |
Brand drugs: 2,144 claims; generic drugs: 4,301 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa A Barbor $253 ($253 in general payments such as food, travel and fees) from 1 company. The largest payer was Alcon Vision LLC with $253.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 2 | $253 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.